Authors:
Socinski, MA
Sandler, AB
Miller, LL
Locker, PK
Hanover, CK
Elfring, GL
Israel, VK
Pirotta, N
Natale, RB
Citation: Ma. Socinski et al., Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 19(4), 2001, pp. 1078-1087
Authors:
Meyer, M
Jeong, E
Bolinger, B
Chen, L
Lenehan, P
Slichenmyer, W
Natale, RB
Citation: M. Meyer et al., Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancer, AM J CL ONC, 24(2), 2001, pp. 167-171
Authors:
Huan, SD
Natale, RB
Stewart, DJ
Sartiano, GP
Stella, PJ
Roberts, JD
Symes, AL
Finizio, M
Citation: Sd. Huan et al., A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer, CLIN CANC R, 6(4), 2000, pp. 1333-1336
Authors:
Small, EJ
Meyer, M
Marshall, ME
Reyno, LM
Meyers, FJ
Natale, RB
Lenehan, PF
Chen, L
Slichenmyer, WJ
Eisenberger, M
Citation: Ej. Small et al., Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone, J CL ONCOL, 18(7), 2000, pp. 1440-1450